News
-
-
COMMUNIQUÉ DE PRESSE
Varengold Bank ends third quarter with satisfactory result
Varengold Bank AG reports satisfactory results for the third quarter of 2024, with EBT at EUR 14.6 million and net income at EUR 39.5 million. The bank confirms its expected EBT range of EUR 9 to 13 million for the full year 2024 -
COMMUNIQUÉ DE PRESSE
Beyond Oil Expands into Western Europe with Purchase Order from Mister Noodles Restaurant Chain in Spain
Beyond Oil receives first direct purchase order for its product in Western Europe from Mister Noodles, a Spanish restaurant chain with 20 locations, marking a significant milestone in their global expansion strategy -
-
COMMUNIQUÉ DE PRESSE
Lahontan Announces Increase in Mineral Resources at Santa Fe: 1,539,000 Au Eq oz Indicated, and 411,000 Au Eq oz Inferred
Lahontan Gold Corp. announces updated Mineral Resource Estimate for Santa Fe Mine, Nevada, showing significant increases in gold and silver resources. Key findings detailed -
COMMUNIQUÉ DE PRESSE
GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug
EndoPure Life Sciences to finance first-in-human clinical trials for GB Sciences' cannabinoid-based products through exclusive licensing deal. Aging populations drive global demand for treatments of neurological disorders -
-
COMMUNIQUÉ DE PRESSE
Accenture’s Next Generation Robotics GTM Lead and AI-Expert Dr. Maria Danninger joins Circus Group Advisory Board
Dr. Maria Danninger, Next Gen Robotics GTM Lead at Accenture, joins Circus Group Advisory Board, bringing deep industry knowledge in AI robotics. Her expertise supports Circus Group's future growth plans -
COMMUNIQUÉ DE PRESSE
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference
Zomedica sponsors educational programs at Fetch dvm360 Veterinary Conference, showcasing innovative products for animals and veterinarians. Leading experts to present on veterinary challenges and advances -
COMMUNIQUÉ DE PRESSE
NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology
NanoViricides, Inc. announces interview with Dr. Diwan discussing revolutionary broad-spectrum antiviral clinical drug candidate NV-387 and innovative nanoviricide technology platform
